LincRNA-EPS impairs host antiviral immunity by antagonizing viral RNA-PKR interaction

EMBO Rep. 2022 May 4;23(5):e53937. doi: 10.15252/embr.202153937. Epub 2022 Mar 21.

Abstract

LincRNA-EPS is an important regulator in inflammation. However, the role of lincRNA-EPS in the host response against viral infection is unexplored. Here, we show that lincRNA-EPS is downregulated in macrophages infected with different viruses including VSV, SeV, and HSV-1. Overexpression of lincRNA-EPS facilitates viral infection, while deficiency of lincRNA-EPS protects the host against viral infection in vitro and in vivo. LincRNA-EPS-/- macrophages show elevated expression of antiviral interferon-stimulated genes (ISGs) such as Mx1, Oas2, and Ifit2 at both basal and inducible levels. However, IFN-β, the key upstream inducer of these ISGs, is downregulated in lincRNA-EPS-/- macrophages compared with control cells. RNA pulldown and mass spectrometry results indicate that lincRNA-EPS binds to PKR and antagonizes the viral RNA-PKR interaction. PKR activates STAT1 and induces antiviral ISGs independent of IFN-I induction. LincRNA-EPS inhibits PKR-STAT1-ISGs signaling and thus facilitates viral infection. Our study outlines an alternative antiviral pathway, with downregulation of lincRNA-EPS promoting the induction of PKR-STAT1-dependent ISGs, and reveals a potential therapeutic target for viral infectious diseases.

Keywords: PKR; antiviral immunity; lincRNA-EPS; lncRNA; type I interferon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents
  • Immunity, Innate
  • Interferon-beta / genetics
  • Interferons
  • RNA, Long Noncoding* / genetics
  • RNA, Viral / metabolism

Substances

  • Antiviral Agents
  • RNA, Long Noncoding
  • RNA, Viral
  • Interferon-beta
  • Interferons

Associated data

  • GEO/GSE193326